Sign up for the new Critical Metals Report newsletter!

(6/7/11)

Genetron Receives FDA Breakthrough Approval for Hepatocellular Carcinoma Detection Device
Source: Streetwise Reports (09/30/2020)

Genetron Holdings Ltd. shares traded 25% higher after the company reported it has received Breakthrough Device Designation from the FDA for its blood-based next-generation sequencing test for early hepatocellular carcinoma detection.

Aptorum Shares Skyrocket Upon Launching Infectious Disease Liquid Biopsy Unit
Source: Streetwise Reports (09/29/2020)

Shares of Aptorum Group Ltd. traded nearly 300% higher after the company reported it launched an infectious disease liquid biopsy start-up subsidiary.

GENFIT and LabCorp Form Exclusive Partnership for Novel Liver Disease Diagnostic Test
Source: Streetwise Reports (09/28/2020)

GENFIT SA shares traded 30% higher after the company reported that it entered into an exclusive agreement with LabCorp to commercialize a novel diagnostic liver disease test.

Shares of MobileIron Inc. traded 18% higher after the company reported it has been recognized as a leading Zero Trust eXtended Ecosystem Platform Provider by independent research firm Forrester Wave™.

Owens & Minor Shares Climb 50% after Raising FY/20 Earnings Guidance by 66%
Source: Streetwise Reports (09/24/2020)

Shares of Owens & Minor Inc. reached a new 52-week high after the company raised FY/20 earnings guidance by 66% and advised it expects the positive earnings trend to continue in 2021.

As Helium Prices Skyrocket, Saskatchewan Pure Play Is Rising to the Challenge
Source: Streetwise Reports (09/24/2020)

Small cap Royal Helium holds the second largest helium land position in North America.

JinkoSolar Shares Rise 21% on Q2 Earnings and Positive FY Outlook
Source: Streetwise Reports (09/23/2020)

JinkoSolar shares established a new 52-week high after the company reported Q2/20 financial results that included a 22% increase in year-over-year total revenue.

AIM ImmunoTech Achieves 200% Increase in Survival Results in Late-Stage Pancreatic Cancer Study
Source: Streetwise Reports (09/22/2020)

AIM ImmunoTech shares traded 20% higher after the firm reported it attained statistically significant, two-fold higher survival results in pancreatic cancer from research conducted at Erasmus University Medical Center in the Netherlands.

FDA Grants Ampio Pharma IND and Approves Phase 1 Trial for Inhaled Ampion in COVID-19 Patients
Source: Streetwise Reports (09/21/2020)

Ampio Pharmaceuticals traded 15% higher reaching a new 52-week high after the company reported that the U.S. FDA granted an IND and approved the clinical trial protocol for inhaled Ampion for use in COVID-19 patients with respiratory distress.